1164 related articles for article (PubMed ID: 10672236)
1. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases.
Mattson MP; Pedersen WA; Duan W; Culmsee C; Camandola S
Ann N Y Acad Sci; 1999; 893():154-75. PubMed ID: 10672236
[TBL] [Abstract][Full Text] [Related]
2. Perturbed endoplasmic reticulum function, synaptic apoptosis and the pathogenesis of Alzheimer's disease.
Mattson MP; Gary DS; Chan SL; Duan W
Biochem Soc Symp; 2001; (67):151-62. PubMed ID: 11447832
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits.
Mattson MP; Chan SL
J Mol Neurosci; 2001 Oct; 17(2):205-24. PubMed ID: 11816794
[TBL] [Abstract][Full Text] [Related]
4. Effects of amyloid precursor protein derivatives and oxidative stress on basal forebrain cholinergic systems in Alzheimer's disease.
Mattson MP; Pedersen WA
Int J Dev Neurosci; 1998; 16(7-8):737-53. PubMed ID: 10198821
[TBL] [Abstract][Full Text] [Related]
5. Calcium and neuronal injury in Alzheimer's disease. Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise.
Mattson MP
Ann N Y Acad Sci; 1994 Dec; 747():50-76. PubMed ID: 7847692
[TBL] [Abstract][Full Text] [Related]
6. Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease.
Camandola S; Mattson MP
Biochim Biophys Acta; 2011 May; 1813(5):965-73. PubMed ID: 20950656
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
8. Altered calcium signaling and neuronal injury: stroke and Alzheimer's disease as examples.
Mattson MP; Rydel RE; Lieberburg I; Smith-Swintosky VL
Ann N Y Acad Sci; 1993 May; 679():1-21. PubMed ID: 8512177
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease.
Yan MH; Wang X; Zhu X
Free Radic Biol Med; 2013 Sep; 62():90-101. PubMed ID: 23200807
[TBL] [Abstract][Full Text] [Related]
10. Neuronal and glial calcium signaling in Alzheimer's disease.
Mattson MP; Chan SL
Cell Calcium; 2003; 34(4-5):385-97. PubMed ID: 12909083
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases.
Gu M; Owen AD; Toffa SE; Cooper JM; Dexter DT; Jenner P; Marsden CD; Schapira AH
J Neurol Sci; 1998 Jun; 158(1):24-9. PubMed ID: 9667773
[TBL] [Abstract][Full Text] [Related]
12. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
Beal MF
Ann Neurol; 1992 Feb; 31(2):119-30. PubMed ID: 1349466
[TBL] [Abstract][Full Text] [Related]
13. Metals, oxidative stress and neurodegenerative disorders.
Jomova K; Vondrakova D; Lawson M; Valko M
Mol Cell Biochem; 2010 Dec; 345(1-2):91-104. PubMed ID: 20730621
[TBL] [Abstract][Full Text] [Related]
14. The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases.
Giasson BI; Ischiropoulos H; Lee VM; Trojanowski JQ
Free Radic Biol Med; 2002 Jun; 32(12):1264-75. PubMed ID: 12057764
[TBL] [Abstract][Full Text] [Related]
15. Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders.
Mattson MP
Ann N Y Acad Sci; 2004 Mar; 1012():37-50. PubMed ID: 15105254
[TBL] [Abstract][Full Text] [Related]
16. The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics.
Di Domenico F; Barone E; Perluigi M; Butterfield DA
Antioxid Redox Signal; 2017 Mar; 26(8):364-387. PubMed ID: 27626216
[TBL] [Abstract][Full Text] [Related]
17. Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease.
Barilar JO; Knezovic A; Perhoc AB; Homolak J; Riederer P; Salkovic-Petrisic M
J Neural Transm (Vienna); 2020 Feb; 127(2):231-250. PubMed ID: 32030485
[TBL] [Abstract][Full Text] [Related]
18. The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy.
Shacka JJ; Roth KA; Zhang J
Front Biosci; 2008 Jan; 13():718-36. PubMed ID: 17981582
[TBL] [Abstract][Full Text] [Related]
19. Presenilins and APP in neuritic and synaptic plasticity: implications for the pathogenesis of Alzheimer's disease.
Chan SL; Furukawa K; Mattson MP
Neuromolecular Med; 2002; 2(2):167-96. PubMed ID: 12428810
[TBL] [Abstract][Full Text] [Related]
20. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
